Invasive adenocarcinoma with bronchoalveolar features: A population-based evaluation of the extent of resection in bronchoalveolar cell carcinoma  Bryan.

Slides:



Advertisements
Similar presentations
Manuel J. Antunes, MD, PhD, DSc 
Advertisements

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation  Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.
Stephen R. Broderick, MD, MPHS 
True Negative Predictive Value of Endobronchial Ultrasound in Lung Cancer: Are We Being Conservative Enough?  Bryan A. Whitson, MD, PhD, Shawn S. Groth,
Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L
Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,
Surgical–pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non– small cell lung cancer: A heterogeneous disease  Chung-Ping Hsu, MD,
Survival of patients with distal esophageal and gastric cardia tumors: A population- based analysis of gastroesophageal junction carcinomas  Bryan A. Whitson,
Pulmonary resection for metastases from hepatocellular carcinoma: Factors influencing prognosis  Takahito Nakagawa, MD, Toshiya Kamiyama, MD, Kazuaki.
Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M
Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system  Shamus R.
Yih-Leong Chang, MD, Chen-Tu Wu, MD, Yung-Chie Lee, MD, PhD 
Esophageal submucosa: The watershed for esophageal cancer
Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study  Morihito Okada, MD, PhD, Teruaki Koike, MD, PhD, Masahiko.
Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.
Intrinsic cardiac stem cells are essential for regeneration
Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation  Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
John M. Varlotto, MD, Abram Recht, MD, John C. Flickinger, MD, Laura N
William M. DeCampli, MD, PhD 
Patterns of survival and recurrence after surgical treatment of early stage non–small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial  Stacey.
Go on-pump or off-pump in diabetic patients?
Conditional Cancer-Specific Versus Cardiovascular-Specific Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer  Shawn S. Groth, MD, MS, Natasha.
Pharyngostomy tubes for gastric conduit decompression
Shawn S. Groth, MD, Bryan M. Burt, MD 
The lord of the rings  Antonio Miceli, MD, PhD 
Survival After Lobectomy Versus Segmentectomy for Stage I Non-Small Cell Lung Cancer: A Population-Based Analysis  Bryan A. Whitson, MD, PhD, Shawn S.
Esophagectomy versus endoscopic resection for patients with early-stage adenocarcinoma: Mercedes versus Tesla  Toni Lerut, MD  The Journal of Thoracic.
A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non–small cell lung cancer  Christopher.
Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.
It's not “just a shunt” but sometimes it should be…
Do we need a bibliometrician to know which way the wind is blowing?
Endobronchial Ultrasound-Guided Fine-Needle Aspiration of Mediastinal Lymph Nodes: A Single Institution's Early Learning Curve  Shawn S. Groth, MD, Bryan.
A first start for lung transplantation?
Required area of lymph node sampling during segmentectomy for clinical stage IA non– small cell lung cancer  Hiroaki Nomori, MD, PhD, Yasuomi Ohba, MD,
Stephen R. Broderick, MD, MPHS 
Shawn S. Groth, MD, MS, R. Taylor Ripley, MD, Bryan M. Burt, MD 
Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: Data from the Surveillance Epidemiology.
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Yusuke Takahashi, MD, PhD, Prasad S. Adusumilli, MD 
Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass  Benjamin Medalion, MD, Michael G. Katz, MD,
Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow?  Jules Lin, MD  The Journal of Thoracic and Cardiovascular.
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
Niv Ad, MD, Lawrence M. Wei, MD 
Internal validation of risk models in lung resection surgery: Bootstrap versus training- and-test sampling  Alessandro Brunelli, MD, Gaetano Rocco, MD 
The Ross procedure: Time to reevaluate the guidelines
Manuel J. Antunes, MD, PhD, DSc 
Video-assisted resection for lung cancer results in fewer complications  Lunxu Liu, PhD, MD, FRCS  The Journal of Thoracic and Cardiovascular Surgery 
Pathologic complete response after esophagectomy following neoadjuvant chemoradiation therapy for esophageal carcinoma: A cure sometimes?  Shawn S. Groth,
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Carcinoma of the esophagus: Prognostic significance of histologic type
Extent of lymphadenectomy is associated with oncological efficacy of sublobar resection for lung cancer ≤2 cm  Brendon M. Stiles, MD, Jialin Mao, MD,
The ascent of POEM: Double-tunnel per oral endoscopic re-myotomy
The harder one looks, the more one finds
Bryan M. Burt, MD  The Journal of Thoracic and Cardiovascular Surgery 
Serratus Anterior Transposition Muscle Flaps for Bronchial Coverage: Technique and Functional Outcomes  Shawn S. Groth, MD, Bryan A. Whitson, MD, PhD,
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
Therapeutic R2 resection for pleural mesothelioma
“The more things change…”: The challenges ahead
Kiran H. Lagisetty, David G. Beer, Andrew C. Chang 
Carinal surgery: A single-institution experience spanning 2 decades
Energized lung resections
Of mice and men… The Journal of Thoracic and Cardiovascular Surgery
Who should decide margin length in pulmonary excision of lung cancer?
Surveillance Epidemiology and End Results Evaluation of the Role of Surgery for Stage I Small Cell Lung Cancer  James B. Yu, MD, Roy H. Decker, MD, PhD,
Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found? 
Edward Y. Chan, MD, Michael J. Reardon, MD 
Proceed with caution: The importance of surveillance in patients with pathologic complete response after chemoradiation therapy plus surgery for esophageal.
Presentation transcript:

Invasive adenocarcinoma with bronchoalveolar features: A population-based evaluation of the extent of resection in bronchoalveolar cell carcinoma  Bryan A. Whitson, MD, PhD, Shawn S. Groth, MD, MS, Rafael S. Andrade, MD, Mohi O. Mitiek, MD, Michael A. Maddaus, MD, Jonathan D’Cunha, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 143, Issue 3, Pages 591-600.e1 (March 2012) DOI: 10.1016/j.jtcvs.2011.10.088 Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Sample inclusion and exclusion selection criteria. BAC, Bronchoalveolar cell carcinoma; SEER, Surveillance, Epidemiology, and End Results. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 591-600.e1DOI: (10.1016/j.jtcvs.2011.10.088) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 (A) Overall survival and (B) cancer-specific survival for patients with bronchoalveolar cell carcinoma histologic features who underwent either lobar or sublobar resection. (C) Overall survival and (D) cancer-specific survival for those patients who underwent anatomic resection (lobectomy or segmentectomy) and nonanatomic resection (wedge resection). Survival denoted on y-axis, with time in months along x-axis. Below the graph, number at risk for each is indicated. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 591-600.e1DOI: (10.1016/j.jtcvs.2011.10.088) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions